Q&A with SWOG Patient Advocate Committee Chair Rick Bangs A primary goal of the Kilimanjaro Climb is to raise awareness of cancer clinical trials to ensure that patients and their families have access to studies and can make informed decisions. Rick Bangs, Chair of the SWOG Patient Advocate Committee, recently shared his views on advocacy …
This morning, at SWOG’s group meeting plenary session, Chair Dr. Charles Blanke announced that he will climb Mt. Kilimanjaro in February 2015 – and do so as an effort to raise awareness of, and funding for, cancer clinical trials. Blanke hopes to mobilize support for bridging the funding gaps which result from recent NCI cuts …
In February 2015, SWOG Cancer Research Chair Dr. Charles D. Blanke will climb Mount Kilimanjaro to raise awareness of the importance of cancer clinical trials and to bring attention to the reality of dwindling federal funding for the National Cancer Institute and its National Clinical Trials Network (NCTN). Learn more at the Climb Page.
Michael LeBlanc, PhD
Group Statistician
JOIN OUR EMAIL LIST
"It's difficult to count how many times SWOG research results have contributed to changing a standard of care. It's even more difficult to count how many times they have simply influenced care guidelines."
The latest @SWOG Front Line #SWOGonc
https://www.swog.org/news-events/news/2024/09/13/advancing-care-guidelines-one-trial-time
Yes! So glad you'll be in attendance. Looking forward to hearing about the experience and outcomes! #SWOGonc
The MAPP program is a year-long mentoring intervention designed to engage advanced practice providers with @SWOG and the #NCTN through direct guidance from an experienced peer-mentor.
Applications invited through November 1 #SWOGonc
https://thehopefoundation.org/funding-opportunities/mapp-program/
We're getting ready! Hope to see you there #SWOGonc
Application open now #SWOGonc
https://thehopefoundation.org/funding-opportunities/mapp-program/
Johanna Horn, President & CEO
;